Biotechnology entrepreneurship: leading, managing and commercializing innovative technologies
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
London, United Kingdom ; San Diego, CA, United States ; Cambridge, MA, United States ; Kidlington, Oxford, United Kingdom
Academic Press, an imprint of Elsevier
[2020]
|
| Ausgabe: | Second Edition |
| Schlagworte: | |
| Online-Zugang: | TUM01 |
| Beschreibung: | Includes bibliographical references and index Section I. Understanding biotechnology entrepreneurship - What is biotechnology entrepreneurship? -- A biotechnology entrepreneur's legacy - Henri A. Termeer's story and his advice to entrepreneurs -- A biotechnology entrepreneur's story: from start-up to international contract development and manufacturing organization -- Seven characteristics of successful biotechnology leaders -- Section II. Overview of the biotechnology industry -- Unleashing the promise of biotechnology to help heal, fuel, and feed the world -- Five essential elements and regional influences required to grow and expand a biotechnology cluster or hub -- Section III. The human capital component -- Building, managing, and motivating great teams -- Building human relationship networks -- Mentorship: Why you need a team of mentors to be successful -- Section IV. The innovative technology component -- Understanding biotechnology product sectors -- Technology opportunities: evaluating the idea -- - Understanding biotechnology business models and managing risk -- Directing your technology toward a market problem: What you need to know before using the business model canvas? -- Section V. The emerging biotechnology enterprise -- Company formation, ownership structure, and securities issues -- Licensing the technology: Biotechnology commercialization strategies using university and federal labs -- Intellectual property protection strategies for biotechnology innovations -- Section VI. The financial capital component -- Sources of capital and investor motivations -- How investors really make decisions: What entrepreneurs need to know when raising money -- Securing angel capital and understanding how angel networks operate -- Understanding and securing venture capital: An entrepreneur's perspective -- Financial ramifications of funding a biotechnology venture: What you need to know about valuation and term sheets -- - Your business plan and presentation: Articulating your journey to commercialization -- Investor presentations: What do you need in an investor pitch deck? -- Section VII. Biotechnology product development -- Therapeutic drug development and human clinical trials -- Integrating diagnostic products into the drug development workflow: Applications for companion diagnostics -- The development and commercialization of medical devices -- Commercialization and applications of agricultural biotechnology -- Artificial intelligence: Emerging applications in biotechnology and pharma -- Artificial intelligence in biotechnology: A framework for commercialization -- Regulatory approval and compliances for biotechnology products -- The biomanufacturing of biotechnology products -- Biotechnology products and their customers: Developing a successful market strategy -- Section VIII. Biotechnology product coverage, coding, and reimbursement strategies -- - Getting the word out: Public relations strategies to support biotechnology business goals -- Section IX. The latter-stage biotechnology company -- Company growth stages and the value of corporate culture -- Biotechnology business development: The art of the deal -- Biotech-pharma collaboration-A strategic tool: Case study of Centocor -- The emergence and transformation of China in biotechnology -- Ethical considerations for biotechnology leaders -- Diverse career opportunities in the biotechnology and life sciences industry -- Common biotechnology entrepreneur mistakes and how to avoid them -- Summary |
| Beschreibung: | 1 Online-Ressource |
| ISBN: | 9780128155868 0128155868 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV047043510 | ||
| 003 | DE-604 | ||
| 005 | 20210111 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 201204s2020 |||| o||u| ||||||eng d | ||
| 020 | |a 9780128155868 |9 978-0-12-815586-8 | ||
| 020 | |a 0128155868 |9 0-12-815586-8 | ||
| 035 | |a (ZDB-4-NLEBK)2100046 | ||
| 035 | |a (OCoLC)1225887142 | ||
| 035 | |a (DE-599)BVBBV047043510 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-91 | ||
| 082 | 0 | |a 338.476606 | |
| 084 | |a AL 20900 |0 (DE-625)2826: |2 rvk | ||
| 084 | |a QP 230 |0 (DE-625)141847: |2 rvk | ||
| 084 | |a WF 9710 |0 (DE-625)148460: |2 rvk | ||
| 245 | 1 | 0 | |a Biotechnology entrepreneurship |b leading, managing and commercializing innovative technologies |c edited by Craig Shimasaki, PhD, MBA (CEO, BioSource Consulting Group and Moleculera Labs, Oklahoma City, OK, United States) |
| 250 | |a Second Edition | ||
| 264 | 1 | |a London, United Kingdom ; San Diego, CA, United States ; Cambridge, MA, United States ; Kidlington, Oxford, United Kingdom |b Academic Press, an imprint of Elsevier |c [2020] | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Section I. Understanding biotechnology entrepreneurship - What is biotechnology entrepreneurship? -- A biotechnology entrepreneur's legacy - Henri A. Termeer's story and his advice to entrepreneurs -- A biotechnology entrepreneur's story: from start-up to international contract development and manufacturing organization -- Seven characteristics of successful biotechnology leaders -- Section II. Overview of the biotechnology industry -- Unleashing the promise of biotechnology to help heal, fuel, and feed the world -- Five essential elements and regional influences required to grow and expand a biotechnology cluster or hub -- Section III. The human capital component -- Building, managing, and motivating great teams -- Building human relationship networks -- Mentorship: Why you need a team of mentors to be successful -- Section IV. The innovative technology component -- Understanding biotechnology product sectors -- Technology opportunities: evaluating the idea -- | ||
| 500 | |a - Understanding biotechnology business models and managing risk -- Directing your technology toward a market problem: What you need to know before using the business model canvas? -- Section V. The emerging biotechnology enterprise -- Company formation, ownership structure, and securities issues -- Licensing the technology: Biotechnology commercialization strategies using university and federal labs -- Intellectual property protection strategies for biotechnology innovations -- Section VI. The financial capital component -- Sources of capital and investor motivations -- How investors really make decisions: What entrepreneurs need to know when raising money -- Securing angel capital and understanding how angel networks operate -- Understanding and securing venture capital: An entrepreneur's perspective -- Financial ramifications of funding a biotechnology venture: What you need to know about valuation and term sheets -- | ||
| 500 | |a - Your business plan and presentation: Articulating your journey to commercialization -- Investor presentations: What do you need in an investor pitch deck? -- Section VII. Biotechnology product development -- Therapeutic drug development and human clinical trials -- Integrating diagnostic products into the drug development workflow: Applications for companion diagnostics -- The development and commercialization of medical devices -- Commercialization and applications of agricultural biotechnology -- Artificial intelligence: Emerging applications in biotechnology and pharma -- Artificial intelligence in biotechnology: A framework for commercialization -- Regulatory approval and compliances for biotechnology products -- The biomanufacturing of biotechnology products -- Biotechnology products and their customers: Developing a successful market strategy -- Section VIII. Biotechnology product coverage, coding, and reimbursement strategies -- | ||
| 500 | |a - Getting the word out: Public relations strategies to support biotechnology business goals -- Section IX. The latter-stage biotechnology company -- Company growth stages and the value of corporate culture -- Biotechnology business development: The art of the deal -- Biotech-pharma collaboration-A strategic tool: Case study of Centocor -- The emergence and transformation of China in biotechnology -- Ethical considerations for biotechnology leaders -- Diverse career opportunities in the biotechnology and life sciences industry -- Common biotechnology entrepreneur mistakes and how to avoid them -- Summary | ||
| 650 | 4 | |a Biotechnology industries | |
| 650 | 4 | |a Entrepreneurship | |
| 650 | 0 | 7 | |a Biotechnologische Industrie |0 (DE-588)4208106-3 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Biotechnologische Industrie |0 (DE-588)4208106-3 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Shimasaki, Craig D. |0 (DE-588)1072650118 |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 012815585X |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-0-12-815585-1 |
| 912 | |a ZDB-4-NLEBK | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032450539 | ||
| 966 | e | |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2100046 |l TUM01 |p ZDB-4-NLEBK |q TUM_PDA_EBSCOBAE_Kauf |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804182024451260416 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Shimasaki, Craig D. |
| author2_role | edt |
| author2_variant | c d s cd cds |
| author_GND | (DE-588)1072650118 |
| author_facet | Shimasaki, Craig D. |
| building | Verbundindex |
| bvnumber | BV047043510 |
| classification_rvk | AL 20900 QP 230 WF 9710 |
| collection | ZDB-4-NLEBK |
| ctrlnum | (ZDB-4-NLEBK)2100046 (OCoLC)1225887142 (DE-599)BVBBV047043510 |
| dewey-full | 338.476606 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.476606 |
| dewey-search | 338.476606 |
| dewey-sort | 3338.476606 |
| dewey-tens | 330 - Economics |
| discipline | Allgemeines Biologie Wirtschaftswissenschaften |
| discipline_str_mv | Allgemeines Biologie Wirtschaftswissenschaften |
| edition | Second Edition |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05492nmm a2200505zc 4500</leader><controlfield tag="001">BV047043510</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210111 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">201204s2020 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780128155868</subfield><subfield code="9">978-0-12-815586-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0128155868</subfield><subfield code="9">0-12-815586-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-NLEBK)2100046</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1225887142</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047043510</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.476606</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">AL 20900</subfield><subfield code="0">(DE-625)2826:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QP 230</subfield><subfield code="0">(DE-625)141847:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WF 9710</subfield><subfield code="0">(DE-625)148460:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Biotechnology entrepreneurship</subfield><subfield code="b">leading, managing and commercializing innovative technologies</subfield><subfield code="c">edited by Craig Shimasaki, PhD, MBA (CEO, BioSource Consulting Group and Moleculera Labs, Oklahoma City, OK, United States)</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Second Edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London, United Kingdom ; San Diego, CA, United States ; Cambridge, MA, United States ; Kidlington, Oxford, United Kingdom</subfield><subfield code="b">Academic Press, an imprint of Elsevier</subfield><subfield code="c">[2020]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Section I. Understanding biotechnology entrepreneurship - What is biotechnology entrepreneurship? -- A biotechnology entrepreneur's legacy - Henri A. Termeer's story and his advice to entrepreneurs -- A biotechnology entrepreneur's story: from start-up to international contract development and manufacturing organization -- Seven characteristics of successful biotechnology leaders -- Section II. Overview of the biotechnology industry -- Unleashing the promise of biotechnology to help heal, fuel, and feed the world -- Five essential elements and regional influences required to grow and expand a biotechnology cluster or hub -- Section III. The human capital component -- Building, managing, and motivating great teams -- Building human relationship networks -- Mentorship: Why you need a team of mentors to be successful -- Section IV. The innovative technology component -- Understanding biotechnology product sectors -- Technology opportunities: evaluating the idea -- </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a"> - Understanding biotechnology business models and managing risk -- Directing your technology toward a market problem: What you need to know before using the business model canvas? -- Section V. The emerging biotechnology enterprise -- Company formation, ownership structure, and securities issues -- Licensing the technology: Biotechnology commercialization strategies using university and federal labs -- Intellectual property protection strategies for biotechnology innovations -- Section VI. The financial capital component -- Sources of capital and investor motivations -- How investors really make decisions: What entrepreneurs need to know when raising money -- Securing angel capital and understanding how angel networks operate -- Understanding and securing venture capital: An entrepreneur's perspective -- Financial ramifications of funding a biotechnology venture: What you need to know about valuation and term sheets -- </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a"> - Your business plan and presentation: Articulating your journey to commercialization -- Investor presentations: What do you need in an investor pitch deck? -- Section VII. Biotechnology product development -- Therapeutic drug development and human clinical trials -- Integrating diagnostic products into the drug development workflow: Applications for companion diagnostics -- The development and commercialization of medical devices -- Commercialization and applications of agricultural biotechnology -- Artificial intelligence: Emerging applications in biotechnology and pharma -- Artificial intelligence in biotechnology: A framework for commercialization -- Regulatory approval and compliances for biotechnology products -- The biomanufacturing of biotechnology products -- Biotechnology products and their customers: Developing a successful market strategy -- Section VIII. Biotechnology product coverage, coding, and reimbursement strategies -- </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a"> - Getting the word out: Public relations strategies to support biotechnology business goals -- Section IX. The latter-stage biotechnology company -- Company growth stages and the value of corporate culture -- Biotechnology business development: The art of the deal -- Biotech-pharma collaboration-A strategic tool: Case study of Centocor -- The emergence and transformation of China in biotechnology -- Ethical considerations for biotechnology leaders -- Diverse career opportunities in the biotechnology and life sciences industry -- Common biotechnology entrepreneur mistakes and how to avoid them -- Summary</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnology industries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Entrepreneurship</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biotechnologische Industrie</subfield><subfield code="0">(DE-588)4208106-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Biotechnologische Industrie</subfield><subfield code="0">(DE-588)4208106-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shimasaki, Craig D.</subfield><subfield code="0">(DE-588)1072650118</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">012815585X</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-0-12-815585-1</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032450539</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2100046</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-4-NLEBK</subfield><subfield code="q">TUM_PDA_EBSCOBAE_Kauf</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV047043510 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T16:06:28Z |
| indexdate | 2024-07-10T09:00:58Z |
| institution | BVB |
| isbn | 9780128155868 0128155868 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032450539 |
| oclc_num | 1225887142 |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM |
| owner_facet | DE-91 DE-BY-TUM |
| physical | 1 Online-Ressource |
| psigel | ZDB-4-NLEBK ZDB-4-NLEBK TUM_PDA_EBSCOBAE_Kauf |
| publishDate | 2020 |
| publishDateSearch | 2020 |
| publishDateSort | 2020 |
| publisher | Academic Press, an imprint of Elsevier |
| record_format | marc |
| spelling | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies edited by Craig Shimasaki, PhD, MBA (CEO, BioSource Consulting Group and Moleculera Labs, Oklahoma City, OK, United States) Second Edition London, United Kingdom ; San Diego, CA, United States ; Cambridge, MA, United States ; Kidlington, Oxford, United Kingdom Academic Press, an imprint of Elsevier [2020] 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index Section I. Understanding biotechnology entrepreneurship - What is biotechnology entrepreneurship? -- A biotechnology entrepreneur's legacy - Henri A. Termeer's story and his advice to entrepreneurs -- A biotechnology entrepreneur's story: from start-up to international contract development and manufacturing organization -- Seven characteristics of successful biotechnology leaders -- Section II. Overview of the biotechnology industry -- Unleashing the promise of biotechnology to help heal, fuel, and feed the world -- Five essential elements and regional influences required to grow and expand a biotechnology cluster or hub -- Section III. The human capital component -- Building, managing, and motivating great teams -- Building human relationship networks -- Mentorship: Why you need a team of mentors to be successful -- Section IV. The innovative technology component -- Understanding biotechnology product sectors -- Technology opportunities: evaluating the idea -- - Understanding biotechnology business models and managing risk -- Directing your technology toward a market problem: What you need to know before using the business model canvas? -- Section V. The emerging biotechnology enterprise -- Company formation, ownership structure, and securities issues -- Licensing the technology: Biotechnology commercialization strategies using university and federal labs -- Intellectual property protection strategies for biotechnology innovations -- Section VI. The financial capital component -- Sources of capital and investor motivations -- How investors really make decisions: What entrepreneurs need to know when raising money -- Securing angel capital and understanding how angel networks operate -- Understanding and securing venture capital: An entrepreneur's perspective -- Financial ramifications of funding a biotechnology venture: What you need to know about valuation and term sheets -- - Your business plan and presentation: Articulating your journey to commercialization -- Investor presentations: What do you need in an investor pitch deck? -- Section VII. Biotechnology product development -- Therapeutic drug development and human clinical trials -- Integrating diagnostic products into the drug development workflow: Applications for companion diagnostics -- The development and commercialization of medical devices -- Commercialization and applications of agricultural biotechnology -- Artificial intelligence: Emerging applications in biotechnology and pharma -- Artificial intelligence in biotechnology: A framework for commercialization -- Regulatory approval and compliances for biotechnology products -- The biomanufacturing of biotechnology products -- Biotechnology products and their customers: Developing a successful market strategy -- Section VIII. Biotechnology product coverage, coding, and reimbursement strategies -- - Getting the word out: Public relations strategies to support biotechnology business goals -- Section IX. The latter-stage biotechnology company -- Company growth stages and the value of corporate culture -- Biotechnology business development: The art of the deal -- Biotech-pharma collaboration-A strategic tool: Case study of Centocor -- The emergence and transformation of China in biotechnology -- Ethical considerations for biotechnology leaders -- Diverse career opportunities in the biotechnology and life sciences industry -- Common biotechnology entrepreneur mistakes and how to avoid them -- Summary Biotechnology industries Entrepreneurship Biotechnologische Industrie (DE-588)4208106-3 gnd rswk-swf Biotechnologische Industrie (DE-588)4208106-3 s DE-604 Shimasaki, Craig D. (DE-588)1072650118 edt Erscheint auch als Druck-Ausgabe 012815585X Erscheint auch als Druck-Ausgabe 978-0-12-815585-1 |
| spellingShingle | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies Biotechnology industries Entrepreneurship Biotechnologische Industrie (DE-588)4208106-3 gnd |
| subject_GND | (DE-588)4208106-3 |
| title | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies |
| title_auth | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies |
| title_exact_search | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies |
| title_exact_search_txtP | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies |
| title_full | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies edited by Craig Shimasaki, PhD, MBA (CEO, BioSource Consulting Group and Moleculera Labs, Oklahoma City, OK, United States) |
| title_fullStr | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies edited by Craig Shimasaki, PhD, MBA (CEO, BioSource Consulting Group and Moleculera Labs, Oklahoma City, OK, United States) |
| title_full_unstemmed | Biotechnology entrepreneurship leading, managing and commercializing innovative technologies edited by Craig Shimasaki, PhD, MBA (CEO, BioSource Consulting Group and Moleculera Labs, Oklahoma City, OK, United States) |
| title_short | Biotechnology entrepreneurship |
| title_sort | biotechnology entrepreneurship leading managing and commercializing innovative technologies |
| title_sub | leading, managing and commercializing innovative technologies |
| topic | Biotechnology industries Entrepreneurship Biotechnologische Industrie (DE-588)4208106-3 gnd |
| topic_facet | Biotechnology industries Entrepreneurship Biotechnologische Industrie |
| work_keys_str_mv | AT shimasakicraigd biotechnologyentrepreneurshipleadingmanagingandcommercializinginnovativetechnologies |